STOCKHOLM, Jan. 14, 2026 /PRNewswire/ -- Sobi plans to publish its report for the fourth quarter and full year of 2025 on 5 February 2026 at 08:00 CET. Investors, analysts, and the media are invited ...

Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO:SOBI) announces today that revenue and adjusted EBITA margin for the full year 2025 were higher than previous outlook. Full-year revenue was ...

Sweden’s Sobi has kicked off a rolling biologics license application in the US for SEL-212, vying to become a new option for patients with refractory chronic gout that doesn’t respond to current ...

STOCKHOLM, Jan. 15, 2026 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO: SOBI) announces today that revenue and adjusted EBITA margin for the full year 2025 were higher than previous ...

Sobi has hit the acquisition trail with a deal to buy Arthrosi Therapeutics for up to $1.5 billion, adding a drug in late-stage clinical testing for gout. The deal, which includes a sizeable $950 ...

Approximately 8,000 people in Europe are living with C3G or primary IC-MPGN Aspaveli (pegcetacoplan) is the first treatment of primary IC-MPGN and the first treatment for C3G and primary IC-MPGN for ...

Sobi, a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases, announced that the European Commission (EC) has ...

Approximately 8,000 people in Europe are living with C3G or primary IC-MPGN Aspaveli (pegcetacoplan) is the first treatment of primary IC-MPGN and the first treatment for C3G and primary IC-MPGN for ...

Frank DeVar, son and Catherine Gorham and Rod DeVar, completed his cross country season at the University of Mary Washington. He took first place in the Capital Athletic Conference meet, second place ...

Good morning, everyone, and thank you for joining us today to the SOBI presentation. My name is [ Apolline Gilbert, ] and I will be moderating today's presentation. With that, I'm happy to leave the ...